Your browser doesn't support javascript.
loading
Identification of novel HLA-A*11:01-restricted HPV16 E6/E7 epitopes and T-cell receptors for HPV-related cancer immunotherapy.
Xiong, Chengjie; Huang, Lihong; Kou, Hedan; Wang, Chenwei; Zeng, Xiaomin; Sun, Hanli; Liu, Shangyuan; Wu, Bin; Li, Jingyao; Wang, Xiaoling; Wang, Zibing; Chen, Lin.
Afiliação
  • Xiong C; Guangzhou Medical University-Guangzhou Institute of Biomedicine and Health (GMU-GIBH) Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Huang L; Guangzhou Medical University-Guangzhou Institute of Biomedicine and Health (GMU-GIBH) Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Kou H; Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China.
  • Wang C; Guangzhou Medical University-Guangzhou Institute of Biomedicine and Health (GMU-GIBH) Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Zeng X; Guangzhou Medical University-Guangzhou Institute of Biomedicine and Health (GMU-GIBH) Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Sun H; Guangdong Xiangxue Life Sciences, Guangzhou, China.
  • Liu S; Guangzhou Medical University-Guangzhou Institute of Biomedicine and Health (GMU-GIBH) Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Wu B; Guangzhou Medical University-Guangzhou Institute of Biomedicine and Health (GMU-GIBH) Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Li J; Guangzhou Medical University-Guangzhou Institute of Biomedicine and Health (GMU-GIBH) Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Wang X; Guangzhou Medical University-Guangzhou Institute of Biomedicine and Health (GMU-GIBH) Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Wang Z; Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China chenlin@gzhmu.edu.cn zlyywzb2118@zzu.edu.cn.
  • Chen L; Guangzhou Medical University-Guangzhou Institute of Biomedicine and Health (GMU-GIBH) Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, Guangdong, China chenlin@gzhmu.edu.cn zlyywzb2118@zzu.edu.cn.
J Immunother Cancer ; 10(9)2022 09.
Article em En | MEDLINE | ID: mdl-36180070

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article